News | August 29, 2011

BK Medical Showcases Flex Focus 700 Ultrasound System

August 29, 2011 – BK Medical will showcase its Flex Focus 700 ultrasound system and BK Power Pack at the 13th World Congress of the World Federation for Ultrasound in Medicine and Biology (WFUMB) in Vienna, Austria, Aug. 26-29, 2011.

The system has been very well received since its initial introduction for surgery. The BK Power Pack is a full back-up power solution for the Flex Focus family of ultrasound systems that ensures plug-free imaging for up to four hours, allowing improvements to workflow and potential reductions in patient wait times.

“We use the BK Medical ultrasound systems in interventional radiology primarily for intraoperative guidance to perform ablation and biopsy procedures,” said Brooke Jeffrey, Jr., M.D., section chief, abdominal imaging, Department of Radiology, Stanford University Medical Center. BK Medical has a comprehensive range of innovative, unique transducers that address the specialized needs and clinical challenges of interventional radiologists worldwide. As an example, the high-resolution biplane transducer 8824, with simultaneous imaging in transverse and longitudinal planes, gives precise anatomic and location information needed for needle guidance and multiple interventional procedures.

BK Medical’s IQPAC technology, used in the Flex Focus 700 and 400 systems, and the Pro Focus Ultraview, provides high quality diagnostic images for all patient types. The IQPAC technology combines the company’s proprietary enhanced tissue definition and angular compound imaging technologies to optimize the ultrasound image. As a result, contrast resolution is improved and the tissue margins are more easily visualized. Together, these two technologies enable improved border definition and reduced speckle noise in the image, resulting in improved image quality.

BK Medical recently introduced Advanced Robotic Ultrasound Technology (ART), a complete ultrasound imaging solution for robotic surgery that includes the Flex Focus 700, specialized transducers and tools designed specifically for robotic-assisted surgery. The premium performance ultrasound solution may benefit surgeons performing robotic-assisted radical prostatectomy (RARP) procedures and robotic-assisted partial nephrectomy (RAPN) procedures.

For more information: www.bkmed.com

 

Related Content

Although it is likely that existing ultrasound systems will be repurposed to treat COVID-19 patients, growth is still expected as companies plan to ramp up production. The ultrasound systems market will therefore outpace other diagnostic imaging such as computed tomography (CT) and magnetic resonance imaging (MRI). Leading data and analytics company GlobalData forecasts the market will reach $6bn by 2028, but increased usage due to COVID-19 is anticipated have a tangible effect.
News | Ultrasound Imaging | June 05, 2020
June 5, 2020 — Although it is likely that existing...
Chief among the myriad practical updates to minimize risks for patients and imaging personnel alike is a tiered approach for delaying both outpatient and inpatient cross-sectional interventional procedures

For procedural delays that will not adversely affect patient outcome, Fananapazir and colleagues proposed the following tiered approach for both outpatient and inpatient scenarios: urgent procedures, procedures that should be performed within 2 weeks, procedures that should be performed within 2 months, and procedures that can safely be delayed 2 or 6 months. Courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | June 05, 2020
June 5, 2020 — An...
The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

News | Coronavirus (COVID-19) | May 26, 2020
May 26, 2020  — Philips Healthcare recently received 510(k) clearance from the U.S.
An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019.

An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019. Photo by Dave Fornell.

News | Ultrasound Imaging | May 26, 2020
May 12, 2020 — DiA Imaging Analysis, a provider of AI based ultrasound analysis solutions, said it received a governm
Butterfly iQ devices provide revolutionary portable ultrasound capabilities for faster and easier screening and monitoring
News | Coronavirus (COVID-19) | May 20, 2020
May 20, 2020 —Atrium Health is one of the first major health systems in the nation to put into wide practice a new...
Richard J. Price, Ph.D., of the University of Virginia's School of Medicine and School of Engineering, is using focused soundwaves to overcome the natural 'blood-brain barrier,' which protects the brain from harmful pathogens. Photo courtesy of Dan Addison | UVA Communications

Richard J. Price, Ph.D., of the University of Virginia's School of Medicine and School of Engineering, is using focused soundwaves to overcome the natural 'blood-brain barrier,' which protects the brain from harmful pathogens. Photo courtesy of Dan Addison | UVA Communications

News | Focused Ultrasound Therapy | May 07, 2020
May 7, 2020 — University of Virginia researchers are pioneering the use of...
The new transducer reaches a 30% greater penetration, so clinicians have detailed images and performance they need to make a definitive diagnosis for pediatric patients, reducing the need for additional diagnostic imaging steps
News | Pediatric Imaging | May 06, 2020
May 6, 2020 — Philips announced the ...
Konica Minolta Healthcare's Rede Mini PACS are designed for specialty practices such as orthopedic, urgent care and family medicine clinics
News | PACS | April 28, 2020
April 28, 2020 – Konica Minolta Healthcare Americas released its Rede...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

News | Coronavirus (COVID-19) | April 24, 2020
April 24, 2020 — The Food and Drug Administration (FDA or the Agency) plays a critic